Our impasse in developing a malaria vaccine
β Scribed by Michael F. Good
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 291 KB
- Volume
- 68
- Category
- Article
- ISSN
- 1420-682X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract As World Malaria Day approaches again it is timely, as an immunologically focussed community, to consider the consequence of not yet having an efficacious vaccine but also the progress that is being made and the challenges that we face in developing one. Key issues that need to be addre
The Second National Mental Health Plan [ 1 ] has as one of its key themes, a focus on the quality and effectiveness of services with an emphasis on outcomes for consumers and carers. This focus on quality and outcomes results in an increasing interest in clinical practice guidelines, benchmarking of
Strain CR326F of hepatitis A virus, derived from a fecal specimen of Costa Rican patient 033-03, was passed 15 times in fetal rhesus monkey kidney (FRhK6) cell cultures plus eight times in human diploid lung (MRC5) cell cultures to yield variant F and 16 times in MRC5 cell cultures to yield variant